Itron (ITRI) Reports Q3 Earnings: What Key Metrics Have to Say

Itron (ITRI) reported $581.63 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 5.5%. EPS of $1.54 for the same period compares to $1.84 a year ago.The reported revenue represents a surprise of +0.9% over the Zacks Consensus Estimate of $576.45 million. With the consensus EPS estimate being $1.48, the EPS surprise was +4.05%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Itron performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Device Solutions: $103.62 million compared to the $111.07 million average estimate based on four analysts. The reported number represents a change of -15.6% year over year.Revenue- Networked Solutions: $393.7 million compared to the $383.53 million average estimate based on four analysts. The reported number represents a change of -5.5% year over year.Revenue- Outcomes: $84.3 million compared to the $82.67 million average estimate based on four analysts. The reported number represents a change of +10.9% year over year.Revenue- Total Product Revenue: $494.32 million compared to the $499.62 million average estimate based on three analysts. The reported number represents a change of -8.2% year over year.Service Revenue- Device Solutions: $0.53 million versus $1.18 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -15.2% change.Revenue- Total Service Revenue: $87.3 million versus $77.03 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change.Service Revenue- Networked Solutions: $28.32 million versus the three-analyst average estimate of $25.37 million. The reported number represents a year-over-year change of +6.8%.Product Revenue- Device Solutions: $103.1 million compared to the $111.12 million average estimate based on three analysts. The reported number represents a change of -15.6% year over year.Product Revenue- Networked Solutions: $365.38 million versus $356.13 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -6.4% change.Service Revenue- Outcomes: $58.45 million versus $53.37 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +16.7% change.Product Revenue- Outcomes: $25.85 million compared to the $24.76 million average estimate based on two analysts. The reported number represents a change of -0.3% year over year.Gross Profit- Device Solutions: $32.01 million versus $33.01 million estimated by two analysts on average.View all Key Company Metrics for Itron here>>>Shares of Itron have returned +12.9% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Itron, Inc. (ITRI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks